Suresh Durgam

Dr. Durgam joined the Company as Senior Vice President, Late Stage Clinical Development and Medical Affairs in August 2018. Dr. Durgam, brings over 15 years of experience in neuropsychiatric drug development, including the development of antipsychotics and antidepressants. Suresh served in clinical development leadership roles at Allergan plc where he was the clinical lead responsible for development of treatments for mood disorders including ripastinel, and other rapid-acting antidepressant programs. Dr. Durgam was also the clinical development lead of the antipsychotic, cariprazine, advancing the compound from Phase I to approval in schizophrenia and bipolar disorder. Dr. Durgam graduated with his medical degree from the Siddhartha Medical College in India and received his residency training in psychiatry at Scott & White Clinic and Hospital – Texas A&M University System College of Medicine.